<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Physiology - NEET PG 2024</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Physiology - NEET PG 2024</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                16 Questions | 16 Total Marks | 26 min Duration | ~97.5 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 16 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 26 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 16</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Physiology - NEET PG 2024 - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 16</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 16 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A man presents with a mixed infection of Plasmodium vivax and Plasmodium falciparum in a health centre in Rajasthan. What is the dosage of the treatment given on the second day?", "options": [{"label": "A", "text": "4 tablets of Artesunate 50mg + 6 tablets of Primaquine 2.5mg", "correct": true}, {"label": "B", "text": "4 tablets of Artesunate 50mg + 6 tablets of Primaquine 7.5mg", "correct": false}, {"label": "C", "text": "4 tablets of Artesunate 50mg 49.05% + Sulphadoxine 1500mg + 6 tablets of Primaquine 2.5mg", "correct": false}, {"label": "D", "text": "4 tablets of Artesunate 45mg + Sulphadoxine 1500mg + 6 tablets of Primaquine 7.5mg", "correct": false}], "correct_answer": "A. 4 tablets of Artesunate 50mg + 6 tablets of Primaquine 2.5mg", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>4 tablets of Artesunate 50mg + 6 tablets of Primaquine 2.5mg Mixed P. falciparum and P. vivax infection: This is to be treated as falciparum malaria with ACT other than artesunate + sulfa-pyrimethamine, because sulfa-pyrimethamine is not effective against P. vivax. Anti relapse treatment with a 14-day course of primaquine may be started concurrently. Artesunate plus Sulfadoxine/pyrimethamine is given on 1st day, and from 2nd day artesunate plus primaquine.</p>\n<p><strong>Highyeild:</strong></p><p>Advantages of ACT over other antimalarials are: Rapid clinical and parasitological cure. High cure rates (>95%) and low recrudescence rate. Absence of parasite resistance (the components prevent development of resistance to each other). Good tolerability profile One orally available ACT includes a tablet with artemether coformulated with lumefantrine and is used for the treatment of uncomplicated malaria. Artesunate may be combined with sulfadoxineâ€“pyrimethamine, mefloquine, clindamycin, or others. The antimalarial action of artemisinin derivatives involves the production of free radicals resulting from cleavage of the drugâ€™s endoperoxide bridge by heme iron in the parasite food vacuole. Oral, rectal, IM and intravenous (IV) preparations are available, but the short half-lives preclude the use of these drugs for prophylaxis. Adverse effects include nausea, vomiting, and diarrhea. High doses may cause prolongation of the QT interval. Hypersensitivity reactions and rash have occurred. Oral ACTs are not to be used in severe or complicated malaria, for which parenteral drugs are needed</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. is incorrect as for 15 (2.5 * 6) mg dose of primaquine is given, so option A is correct. Option: C. is incorrect as 4 tablets of Artesunate 50mg + 6 tablets of Primaquine 2.5mg is preferred choice for mixed infection on 2nd day. Option: D. is incorrect as 4 tablets of Artesunate 50mg + 6 tablets of Primaquine 2.5mg is preferred choice for mixed infection on 2nd day.</p>\n<p><strong>Table:</strong></p><p>#MANTRA Life cycle of the malarial parasite, showing the sites of action of antimalarial drugs.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following beta-adrenergic blockers are beneficial for patients with reduced ejection fraction and can reduce mortality in chronic heart failure without causing exacerbations over a few years?", "options": [{"label": "A", "text": "Propranolol", "correct": false}, {"label": "B", "text": "Pindolol", "correct": false}, {"label": "C", "text": "Esmolol", "correct": false}, {"label": "D", "text": "Bisoprolol", "correct": true}], "correct_answer": "D. Bisoprolol", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Bisoprolol Beta blocker approved for chronic CHF are metoprolol, bisoprolol and carvedilol. Hence, option D is correct. Introduced gradually and maintained for long term, these drugs retard the progression of CHF and prolong life. The benefit may result from antagonism of deleterious effects of sympathetic overactivity (invoked reflexly by heart failure) on the myocardium.</p>\n<p><strong>Highyeild:</strong></p><p>Beta blocker in Congestive heart failure: Although Î² blockers can acutely worsen heart failure, several studies have reported beneficial haemodynamic effects of certain Î² blockers, namely metoprolol, bisoprolol, nebivolol and carvedilol over long-term in selected patients with dilated cardiomyopathy. Introduced gradually and maintained for long term, these drugs retard the progression of CHF and prolong life . The benefit may result from antagonism of deleterious effects of sympathetic overactivity (invoked reflexly by heart failure) on the myocardium. Overactivation of cardiac Î²1 receptors has been found to exert toxic effects on the heart by accelerating myocyte apoptosis and promoting functionally unfavourable remodeling. However, these drugs should not be given to patients with marked fluid retention and to those who worsen on initiating the Î² blocker, or to those requiring i.v. vasodilators/i.v. inotropic drugs.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - OPTION: A. is incorrect as bisoprolol is used for CHF and can reduce mortality in chronic heart failure without causing exacerbations over a few years. OPTION: B. is incorrect as bisoprolol is used for CHF and can reduce mortality in chronic heart failure without causing exacerbations over a few years. OPTION: C. is incorrect as bisoprolol is used for CHF and can reduce mortality in chronic heart failure without causing exacerbations over a few years.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 75-year-old female presented with urinary incontinence. She also has cognitive decline and dementia. Which of the following drugs is useful for treating urinary incontinence?", "options": [{"label": "A", "text": "Tiotropium", "correct": false}, {"label": "B", "text": "Ipratropium", "correct": false}, {"label": "C", "text": "Tolterodine", "correct": true}, {"label": "D", "text": "Telenzepine", "correct": false}], "correct_answer": "C. Tolterodine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Tolterodine Tolterodine is a M3 selective muscarinic antagonist that has preferential action on urinary bladder; It is indicated in overactive bladder with urinary frequency and urgency.</p>\n<p><strong>Highyeild:</strong></p><p>Tolterodine: This relatively M3 selective muscarinic antagonist has preferential action on the urinary bladder; less likely to cause dryness of mouth and other anticholinergic side effects. It is indicated in overactive bladder with urinary frequency and urgency. Since it is metabolized by CYP3A4, dose should be halved in patients receiving CYP3A4 inhibitors (erythromycin, ketoconazole, etc.)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. is incorrect as Tolterodine is a M3 selective muscarinic antagonist and indicated in overactive bladder with urinary frequency and urgency. Tiotropium is used in COPD. Option: B. is incorrect as Tolterodine is a M3 selective muscarinic antagonist and indicated in overactive bladder with urinary frequency and urgency. Ipratropium is used in COPD. Option: D. is incorrect as Tolterodine is a M3 selective muscarinic antagonist and indicated in overactive bladder with urinary frequency and urgency. Telenzepine is M1 muscarinic receptors and inhibits gastric secretion.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which drug is used to treat multiple myeloma that is known to cause reactivation of Herpes Zoster?", "options": [{"label": "A", "text": "Bortezomib", "correct": true}, {"label": "B", "text": "Lenalidomide", "correct": false}, {"label": "C", "text": "Daratumumab", "correct": false}, {"label": "D", "text": "Elotuzumab", "correct": false}], "correct_answer": "A. Bortezomib", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Bortezomib Bortezomib is a first-generation inhibitor of proteasome-mediated protein degradation that has a central role in the treatment of MM. It has immunosuppressant properties and can reactivate herpes zoster virus. Patients should receive antiviral prophylaxis if they are receiving therapy with bortezomib.</p>\n<p><strong>Highyeild:</strong></p><p>Proteasome inhibitors: Bortezomib , ixazomib , and carfilzomib are proteasome inhibitors commonly used as the backbone therapy in the treatment of multiple myeloma. These agents work by inhibiting proteasomes, which in turn prevents the degradation of proapoptotic factors, thus leading to a promotion in programmed cell death (apoptosis). Malignant cells readily depend on suppression of the apoptotic pathway; therefore, proteasome inhibition works well in multiple myeloma. Bortezomib can be administered IV, but the subcutaneous route is preferred because it is associated with less neuropathy. Other adverse effects include myelosuppression, diarrhea, nausea, fatigue, and herpes zoster reactivation. Patients should receive antiviral prophylaxis if they are receiving therapy with bortezomib. Ixazomib is an oral agent with an adverse effect profile similar to bortezomib. Carfilzomib is administered intravenously, and common adverse effects include myelosuppression, fatigue, nausea, diarrhea, and fever</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. is incorrect as Bortezomib can cause herpes zoster reactivation. Option: C. is incorrect as Bortezomib can cause herpes zoster reactivation. Option: D. is incorrect as Bortezomib can cause herpes zoster reactivation.</p>\n<p><strong>Table:</strong></p><p>#MANTRA</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient presented with breathing difficulty and nasal polyposis when he took aspirin for fever. He faced this issue previously too when he took aspirin. Which among the following is not true about this?", "options": [{"label": "A", "text": "There is no allergic sensitization to aspirin and its metabolites", "correct": false}, {"label": "B", "text": "Responds to Montelukast", "correct": false}, {"label": "C", "text": "Occur on exposure to only aspirin", "correct": true}, {"label": "D", "text": "Occurs with exposure to other NSAIDs too that block COX 1", "correct": false}], "correct_answer": "C. Occur on exposure to only aspirin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Occur on exposure to only aspirin Aspirin-exacerbated respiratory disease (AERD), also known as Samterâ€™s Triad, is a chronic medical condition that consists of three clinical features: asthma, sinus disease with recurrent nasal polyps, and sensitivity to aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) that inhibit an enzyme called cyclooxygenase-1. The characteristic feature of AERD is that patients develop reactions to aspirin and other NSAIDs. Hence, option C is incorrect.</p>\n<p><strong>Highyeild:</strong></p><p>ASPIRIN- Aspirin is a NSAIDS and exhibits anti-inflammatory activity only at relatively high doses that are rarely used. It is used more frequently at lower doses to prevent cardiovascular events such as stroke and myocardial infarction (MI). Aspirin is often differentiated from other NSAIDs since it is an irreversible inhibitor of cyclooxygenase activity. Aspirin is often differentiated from other NSAIDs since it is an irreversible inhibitor of cyclooxygenase activity Aspirin Side Effects ASPIRIN Asthma S alicylates intolerance Peptic ulcer I ntestinal/gastro bleeding Reye